Basics |
Company: |
Oramed Pharmaceuticals Inc. |
IPO Date: |
May 1, 2007 |
Sector: |
Healthcare |
Industry: |
Pharma |
Market Cap: |
$86.67M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.23 | 3.00%
|
Avg Daily Range (30 D): |
$0.04 | 1.82%
|
Avg Daily Range (90 D): |
$0.04 | 1.83%
|
Institutional Daily Volume |
Avg Daily Volume: |
.26M |
Avg Daily Volume (30 D): |
.37M |
Avg Daily Volume (90 D): |
.22M |
Trade Size |
Avg Trade Size (Sh.): |
161 |
Avg Trade Size (Sh.) (30 D): |
286 |
Avg Trade Size (Sh.) (90 D): |
269 |
Institutional Trades |
Total Inst.Trades: |
113 |
Avg Inst. Trade: |
$1.66M |
Avg Inst. Trade (30 D): |
$.63M |
Avg Inst. Trade (90 D): |
$.63M |
Avg Inst. Trade Volume: |
.17M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$3.39M |
Avg Closing Trade (30 D): |
$M |
Avg Closing Trade (90 D): |
$M |
Avg Closing Volume: |
297.23K |
|
|
|
|
Financials |
|
TTM |
Q2 2024 |
Q1 2024 |
Basic EPS
|
$-.48
|
$.22
|
$.04
|
Diluted EPS
|
$-.48
|
$.22
|
$.04
|
Revenue
|
$
|
$
|
$
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -19.64M
|
$ 9.2M
|
$ 1.53M
|
Operating Income / Loss
|
$ -3.09M
|
$ -3.14M
|
$ -2.96M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -42.65M
|
$ 66.18M
|
$ 9.52M
|
PE Ratio
|
|
|
|
Splits |
Jan 23, 2013:
12:1
|
|